John Flavin
Founder at PYXIS ONCOLOGY, INC.
Net worth: 2 M $ as of 2024-04-29
John Flavin active positions
Companies | Position | Start | End |
---|---|---|---|
PYXIS ONCOLOGY, INC. | Founder | 2018-06-10 | - |
Chairman | 2018-06-10 | - | |
Independent Dir/Board Member | 2019-12-10 | - | |
Director/Board Member | 2019-12-10 | - | |
Flavin Ventures LLC | Corporate Officer/Principal | 2010-01-03 | - |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Chief Executive Officer | 2022-02-28 | - |
Founder | 2020-02-29 | - | |
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Chairman | - | - |
Career history of John Flavin
Former positions of John Flavin
Companies | Position | Start | End |
---|---|---|---|
Endotronix, Inc.
Endotronix, Inc. Medical SpecialtiesHealth Technology Endotronix, Inc. develops wireless heart sensor technology. The firm has introduced the Cordella Heart Failure System, a comprehensive solution for heart failure management. The company was founded by Anthony I. Nunez and Harry D. Rowland in June 2007 and is headquartered in Lisle, IL. | Director of Finance/CFO | 2018-03-31 | 2020-01-31 |
ADVANCED LIFE SCIENCES HOLDINGS, INC. | Director/Board Member | 2002-05-31 | 2011-05-04 |
Director of Finance/CFO | 2011-05-04 | 2011-05-04 | |
President | - | 2011-05-04 | |
Corporate Secretary | 2011-05-04 | 2011-05-04 | |
MediChem Life Sciences, Inc.
MediChem Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million. | Chief Operating Officer | 2000-04-30 | 2002-04-30 |
Director of Finance/CFO | 1990-12-31 | 2000-04-30 | |
President | 1990-12-31 | 2000-04-30 | |
Advanced X-Ray Analytical Services, Inc. | President | - | - |
ThermoGen, Inc.
ThermoGen, Inc. Medical SpecialtiesHealth Technology ThermoGen, Inc. develops biocatalysts for pharmaceutical production. The company was headquartered in Chicago, IL. | President | - | - |
░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - | - |
Training of John Flavin
Lewis University | Masters Business Admin |
Marquette University | Undergraduate Degree |
Statistics
International
United States | 13 |
Operational
President | 5 |
Director of Finance/CFO | 3 |
Director/Board Member | 2 |
Sectoral
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PYXIS ONCOLOGY, INC. | Health Technology |
Private companies | 9 |
---|---|
MediChem Life Sciences, Inc.
MediChem Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million. | Commercial Services |
Advanced Life Sciences Holdings, Inc.
Advanced Life Sciences Holdings, Inc. BiotechnologyHealth Technology Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel drugs in therapeutic areas of infection, cancer and inflammation. Its product candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of life-threatening infections including community-aquired bacterial pneumonia and biodefense pathogens including anthrax, plague and tularemia. The company was founded by Michael T. Flavin on January 1, 1999 and is headquartered in Woodridge, IL. | Health Technology |
Endotronix, Inc.
Endotronix, Inc. Medical SpecialtiesHealth Technology Endotronix, Inc. develops wireless heart sensor technology. The firm has introduced the Cordella Heart Failure System, a comprehensive solution for heart failure management. The company was founded by Anthony I. Nunez and Harry D. Rowland in June 2007 and is headquartered in Lisle, IL. | Health Technology |
Emerald BioStructures, Inc.
Emerald BioStructures, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beryllium LLC, Emerald BioStructures, Inc. is a company that offers products and services in protein X-ray crystallography, specializing in the area of protein crystallization. The company is based in Bainbridge Island, WA. The company was founded by Lance K. Stewart. Emerald BioStructures was acquired by MediChem Research, Inc. on May 31, 2000. | Commercial Services |
ThermoGen, Inc.
ThermoGen, Inc. Medical SpecialtiesHealth Technology ThermoGen, Inc. develops biocatalysts for pharmaceutical production. The company was headquartered in Chicago, IL. | Health Technology |
Flavin Ventures LLC | |
Advanced X-Ray Analytical Services, Inc. | |
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Health Technology |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Finance |
- Stock Market
- Insiders
- John Flavin
- Experience